A detailed history of Excalibur Management Corp transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Excalibur Management Corp holds 834 shares of TMO stock, worth $428,058. This represents 0.2% of its overall portfolio holdings.

Number of Shares
834
Previous 846 1.42%
Holding current value
$428,058
Previous $467,000 10.28%
% of portfolio
0.2%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$531.86 - $624.21 $6,382 - $7,490
-12 Reduced 1.42%
834 $515,000
Q2 2024

Aug 09, 2024

SELL
$541.52 - $599.02 $5,415 - $5,990
-10 Reduced 1.17%
846 $467,000
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $4,230 - $4,795
8 Added 0.94%
856 $497,000
Q4 2023

Feb 12, 2024

SELL
$431.41 - $532.94 $29,335 - $36,239
-68 Reduced 7.42%
848 $450,000
Q3 2023

Nov 09, 2023

BUY
$498.29 - $574.41 $4,982 - $5,744
10 Added 1.1%
916 $463,000
Q1 2023

May 05, 2023

SELL
$535.0 - $604.82 $5,350 - $6,048
-10 Reduced 1.09%
906 $522,000
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $4,847 - $5,713
-10 Reduced 1.08%
916 $504,000
Q1 2022

May 03, 2022

SELL
$524.0 - $644.92 $1,572 - $1,934
-3 Reduced 0.32%
926 $547,000
Q4 2021

Feb 10, 2022

SELL
$569.0 - $667.24 $64,866 - $76,065
-114 Reduced 10.93%
929 $620,000
Q2 2021

Jul 26, 2021

SELL
$441.0 - $508.24 $2,205 - $2,541
-5 Reduced 0.48%
1,043 $526,000
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $825 - $1,087
-3 Reduced 0.29%
1,048 $380,000
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $1,531 - $2,040
6 Added 0.57%
1,051 $298,000
Q4 2019

Feb 04, 2020

BUY
$271.93 - $328.04 $284,166 - $342,801
1,045 New
1,045 $339,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Excalibur Management Corp Portfolio

Follow Excalibur Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.